Objectives

• Participants will know the incidence and risk factors for CTEPH
• Explain the mechanisms of PH in chronic thromboembolic disease
• Know the current and upcoming options for long term anticoagulation
• Integrate an understanding of physiological concepts into the management of patients with CTEPH
• Able to evaluate the surgical options for CTEPH

Goals

• Learn to recognize and evaluate CTEPH
• Review the current approach for the assessment of CTEPH
• Update on the new anticoagulation medications available for venous thromboembolic disease
• Increase knowledge in the role of radiology for CTEPH
• Describe recent advances in the medical and surgical management of CTEPH

Target Audience

Practitioners interested in learning more about advances in the understanding of the pathophysiology and treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH).

Cardiologists, respirologists, thoracic surgeons, rheumatologists, internists, hematologists

Course Directors

Marc de Perrot, MD, MSc, Division of Thoracic Toronto General Hospital Associate Prof. of Surgery, University of Toronto Division of Thoracic Surgery

John Granton, MD, FRCP Division of Respirology, University Health Network, Mount Sinai Hospital and Women’s College Hospital Associate Prof. of Medicine, Faculty of Medicine, University of Toronto